220 related articles for article (PubMed ID: 29212421)
21. Outcomes from cardiac surgery in Jehovah's witness patients: experience over twenty-one years.
Marinakis S; Van der Linden P; Tortora R; Massaut J; Pierrakos C; Wauthy P
J Cardiothorac Surg; 2016 Apr; 11(1):67. PubMed ID: 27079663
[TBL] [Abstract][Full Text] [Related]
22. Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study.
Nanni G; Vitolo M; Imberti JF; Girolami D; Bonini N; Valenti AC; Cimato P; Boriani G
Intern Emerg Med; 2023 Jan; 18(1):151-162. PubMed ID: 36401716
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion.
Hogervorst EK; Rosseel PM; van de Watering LM; Brand A; Bentala M; van der Bom JG; van der Meer NJ
J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):363-72. PubMed ID: 26809765
[TBL] [Abstract][Full Text] [Related]
24. Jehovah's Witnesses and cardiac surgery: a single institution's experience.
McCartney S; Guinn N; Roberson R; Broomer B; White W; Hill S
Transfusion; 2014 Oct; 54(10 Pt 2):2745-52. PubMed ID: 24809815
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
Zenz T; Döhner H; Bunjes D
Bone Marrow Transplant; 2003 Aug; 32(4):437-8. PubMed ID: 12900782
[TBL] [Abstract][Full Text] [Related]
26. Life-Threatening Pancreatitis in Jehovah's Witness Patients With Severe Anemia Treated Without Transfusions and by Interventional Radiology Techniques.
Kishi P; vanSonnenberg E; Stroker M
J Intensive Care Med; 2019 Feb; 34(2):165-170. PubMed ID: 29902958
[TBL] [Abstract][Full Text] [Related]
27. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
[TBL] [Abstract][Full Text] [Related]
28. Acute leukaemia in Jehovah's Witnesses.
Cullis JO; Duncombe AS; Dudley JM; Lumley HS; Apperley JF; Smith AG
Br J Haematol; 1998 Mar; 100(4):664-8. PubMed ID: 9531331
[TBL] [Abstract][Full Text] [Related]
29. Children of Jehovah's Witnesses and adolescent Jehovah's Witnesses: what are their rights?
Woolley S
Arch Dis Child; 2005 Jul; 90(7):715-9. PubMed ID: 15970615
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute myeloid leukemia in a Jehovah's Witness.
Dalal S; Boddapati M; Lowery MN; Veillon DM; Glass J; Munker R
Ann Hematol; 2006 Jun; 85(6):407-8. PubMed ID: 16518601
[No Abstract] [Full Text] [Related]
31. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
[TBL] [Abstract][Full Text] [Related]
32. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
[TBL] [Abstract][Full Text] [Related]
33. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
Ford PA; Grant SJ; Mick R; Keck G
J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
[TBL] [Abstract][Full Text] [Related]
34. Safety of cardiac surgery without blood transfusion: a retrospective study in Jehovah's Witness patients.
El Azab SR; Vrakking R; Verhage G; Rosseel PM
Anaesthesia; 2010 Apr; 65(4):348-52. PubMed ID: 20402872
[TBL] [Abstract][Full Text] [Related]
35. Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.
Sagy I; Jotkowitz A; Barski L
J Relig Health; 2017 Apr; 56(2):732-738. PubMed ID: 28035631
[TBL] [Abstract][Full Text] [Related]
36. ENT surgery, blood and Jehovah's Witnesses.
Woolley SL; Smith DR
J Laryngol Otol; 2007 May; 121(5):409-14. PubMed ID: 17125571
[TBL] [Abstract][Full Text] [Related]
37. Transfusion support and alternatives for Jehovah's Witness patients.
Crowe EP; DeSimone RA
Curr Opin Hematol; 2019 Nov; 26(6):473-479. PubMed ID: 31453819
[TBL] [Abstract][Full Text] [Related]
38. Bloodless lung transplantation in Jehovah's Witnesses: impact on perioperative parameters and outcome compared with a matched control group.
Partovi S; Bruckner BA; Staub D; Ortiz G; Scheinin SA; Seethamraju H; Loebe M
Transplant Proc; 2013; 45(1):335-41. PubMed ID: 23267815
[TBL] [Abstract][Full Text] [Related]
39. Remission induction in a Jehovah's witness patient with acute myeloid leukaemia using gemtuzumab ozogamicin.
Bareford D; Odeh B; Narayanan S; Wiltshire S
Transfus Med; 2005 Oct; 15(5):445-8. PubMed ID: 16202062
[TBL] [Abstract][Full Text] [Related]
40. Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases.
Oh SY; Kim SH; Kwon HC; Lee S; Kim KH; Kwon KA; Lee JH; Lee KY; Kim HJ
Support Care Cancer; 2010 Oct; 18(10):1341-6. PubMed ID: 19841950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
